Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects

Gene Jack Wang, Nora D. Volkow, Jean Logan, Joanna S. Fowler, David Schlyer, Robert R. MacGregor, Robert Hitzemann, Ruben C. Gur, Alfred P. Wolf

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

We assessed the relation between serotonin 5-HT2 receptor availability and aging and compared it with that for dopamine D2 receptors on 19 healthy male volunteers (age range, 21-49 years) using positron emission tomography (PET) and F-18 N-methylspiperone (NMS). 5-HT2 Receptor availability was obtained using the ratio of the distribution volume in the region of interest to that in the cerebellum ( Bmax′ Kd′ + 1). 5-HT2 Receptor measures were obtained in frontal and occipital cortices. D2 receptor availability in striatum was measured using the "ratio index". 5-HT2 Receptor availability decreased significantly with age. This effect was significantly more accentuated for 5-HT2 receptor availability in the frontal (r = 0.92, p ≤ 0.0001) than in the occipital (r = 0.67, p ≤ 0.0016) cortex (df = l, p <0.025). Dopamine D2 receptors were also found to decrease significantly with age (r = 0.63, p ≤ 0.007). In a given subject, striatal D2 receptor availability significantly correlated with 5-HT2 receptor availability in the frontal (r = 0.51, p ≤ 0.035) but not in the occipital cortex. These results document a decline in 5-HT2 and D2 receptor availability with age and showed an association between frontal 5-HT2 and striatal D2 receptors.

Original languageEnglish (US)
JournalLife Sciences
Volume56
Issue number14
DOIs
StatePublished - Feb 24 1995
Externally publishedYes

Fingerprint

Corpus Striatum
Occipital Lobe
Dopamine D2 Receptors
Serotonin
Healthy Volunteers
Serotonin 5-HT2 Receptors
Availability
Frontal Lobe
Positron-Emission Tomography
Cerebellum
Positron emission tomography
Aging of materials

Keywords

  • aging
  • dopamine D
  • serotonin 5-HT

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology

Cite this

Wang, G. J., Volkow, N. D., Logan, J., Fowler, J. S., Schlyer, D., MacGregor, R. R., ... Wolf, A. P. (1995). Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sciences, 56(14). https://doi.org/10.1016/0024-3205(95)00066-F

Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. / Wang, Gene Jack; Volkow, Nora D.; Logan, Jean; Fowler, Joanna S.; Schlyer, David; MacGregor, Robert R.; Hitzemann, Robert; Gur, Ruben C.; Wolf, Alfred P.

In: Life Sciences, Vol. 56, No. 14, 24.02.1995.

Research output: Contribution to journalArticle

Wang, Gene Jack ; Volkow, Nora D. ; Logan, Jean ; Fowler, Joanna S. ; Schlyer, David ; MacGregor, Robert R. ; Hitzemann, Robert ; Gur, Ruben C. ; Wolf, Alfred P. / Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. In: Life Sciences. 1995 ; Vol. 56, No. 14.
@article{e39313ac3f2349878c344c67ea0cc0f8,
title = "Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects",
abstract = "We assessed the relation between serotonin 5-HT2 receptor availability and aging and compared it with that for dopamine D2 receptors on 19 healthy male volunteers (age range, 21-49 years) using positron emission tomography (PET) and F-18 N-methylspiperone (NMS). 5-HT2 Receptor availability was obtained using the ratio of the distribution volume in the region of interest to that in the cerebellum ( Bmax′ Kd′ + 1). 5-HT2 Receptor measures were obtained in frontal and occipital cortices. D2 receptor availability in striatum was measured using the {"}ratio index{"}. 5-HT2 Receptor availability decreased significantly with age. This effect was significantly more accentuated for 5-HT2 receptor availability in the frontal (r = 0.92, p ≤ 0.0001) than in the occipital (r = 0.67, p ≤ 0.0016) cortex (df = l, p <0.025). Dopamine D2 receptors were also found to decrease significantly with age (r = 0.63, p ≤ 0.007). In a given subject, striatal D2 receptor availability significantly correlated with 5-HT2 receptor availability in the frontal (r = 0.51, p ≤ 0.035) but not in the occipital cortex. These results document a decline in 5-HT2 and D2 receptor availability with age and showed an association between frontal 5-HT2 and striatal D2 receptors.",
keywords = "aging, dopamine D, serotonin 5-HT",
author = "Wang, {Gene Jack} and Volkow, {Nora D.} and Jean Logan and Fowler, {Joanna S.} and David Schlyer and MacGregor, {Robert R.} and Robert Hitzemann and Gur, {Ruben C.} and Wolf, {Alfred P.}",
year = "1995",
month = "2",
day = "24",
doi = "10.1016/0024-3205(95)00066-F",
language = "English (US)",
volume = "56",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "14",

}

TY - JOUR

T1 - Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects

AU - Wang, Gene Jack

AU - Volkow, Nora D.

AU - Logan, Jean

AU - Fowler, Joanna S.

AU - Schlyer, David

AU - MacGregor, Robert R.

AU - Hitzemann, Robert

AU - Gur, Ruben C.

AU - Wolf, Alfred P.

PY - 1995/2/24

Y1 - 1995/2/24

N2 - We assessed the relation between serotonin 5-HT2 receptor availability and aging and compared it with that for dopamine D2 receptors on 19 healthy male volunteers (age range, 21-49 years) using positron emission tomography (PET) and F-18 N-methylspiperone (NMS). 5-HT2 Receptor availability was obtained using the ratio of the distribution volume in the region of interest to that in the cerebellum ( Bmax′ Kd′ + 1). 5-HT2 Receptor measures were obtained in frontal and occipital cortices. D2 receptor availability in striatum was measured using the "ratio index". 5-HT2 Receptor availability decreased significantly with age. This effect was significantly more accentuated for 5-HT2 receptor availability in the frontal (r = 0.92, p ≤ 0.0001) than in the occipital (r = 0.67, p ≤ 0.0016) cortex (df = l, p <0.025). Dopamine D2 receptors were also found to decrease significantly with age (r = 0.63, p ≤ 0.007). In a given subject, striatal D2 receptor availability significantly correlated with 5-HT2 receptor availability in the frontal (r = 0.51, p ≤ 0.035) but not in the occipital cortex. These results document a decline in 5-HT2 and D2 receptor availability with age and showed an association between frontal 5-HT2 and striatal D2 receptors.

AB - We assessed the relation between serotonin 5-HT2 receptor availability and aging and compared it with that for dopamine D2 receptors on 19 healthy male volunteers (age range, 21-49 years) using positron emission tomography (PET) and F-18 N-methylspiperone (NMS). 5-HT2 Receptor availability was obtained using the ratio of the distribution volume in the region of interest to that in the cerebellum ( Bmax′ Kd′ + 1). 5-HT2 Receptor measures were obtained in frontal and occipital cortices. D2 receptor availability in striatum was measured using the "ratio index". 5-HT2 Receptor availability decreased significantly with age. This effect was significantly more accentuated for 5-HT2 receptor availability in the frontal (r = 0.92, p ≤ 0.0001) than in the occipital (r = 0.67, p ≤ 0.0016) cortex (df = l, p <0.025). Dopamine D2 receptors were also found to decrease significantly with age (r = 0.63, p ≤ 0.007). In a given subject, striatal D2 receptor availability significantly correlated with 5-HT2 receptor availability in the frontal (r = 0.51, p ≤ 0.035) but not in the occipital cortex. These results document a decline in 5-HT2 and D2 receptor availability with age and showed an association between frontal 5-HT2 and striatal D2 receptors.

KW - aging

KW - dopamine D

KW - serotonin 5-HT

UR - http://www.scopus.com/inward/record.url?scp=0028945622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028945622&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(95)00066-F

DO - 10.1016/0024-3205(95)00066-F

M3 - Article

C2 - 7475891

AN - SCOPUS:0028945622

VL - 56

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 14

ER -